186205714	186205714	CD	B-NP	O
|	|	NNP	I-NP	O
IMC	IMC	NNP	I-NP	O
|	|	VBD	B-VP	O
95673474	95673474	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
260456	260456	CD	B-NP	O
|	|	CC	I-NP	O
8/27/1996	8/27/1996	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/4/1996	10/4/1996	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/1996	11/10/1996	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Hora	Hora	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
45	45	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
diabetes	diabete	NNS	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
sustained	sustained	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
long	long	RB	I-VP	O
standing	stand	VBG	I-VP	O
obesity	obesity	NN	B-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
fairly	fairly	RB	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
and	and	CC	O	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
atypical	atypical	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	I-NP	O
asthma	asthma	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
four	four	CD	I-NP	O
days	day	NNS	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
increased	increase	VBN	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
rather	rather	RB	B-NP	O
persistent	persistent	JJ	I-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
generally	generally	RB	B-ADVP	O
describes	describe	VBZ	B-VP	O
it	it	PRP	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
anterior	anterior	JJ	I-NP	O
chest	chest	NN	I-NP	O
wall	wall	NN	I-NP	O
as	as	IN	B-PP	O
pressure	pressure	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
some	some	DT	B-NP	O
sharp	sharp	JJ	I-NP	O
qualities	quality	NNS	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
without	without	IN	B-PP	O
subjective	subjective	JJ	B-NP	O
wheezing	wheezing	NN	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
unsure	unsure	JJ	B-ADJP	O
of	of	IN	B-PP	O
whether	whether	IN	B-SBAR	O
her	her	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
correlates	correlate	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
has	have	VBZ	B-VP	O
included	include	VBN	I-VP	O
several	several	JJ	B-NP	O
negative	negative	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
tests	test	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
there	there	RB	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
1981	1981	CD	B-NP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
with	with	IN	B-PP	O
Thallium	Thallium	NN	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
fixed	fixed	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
profusion	profusion	NN	I-NP	O
defect	defect	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
EKG	EKG	NNP	I-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
anterolateral	anterolateral	JJ	I-NP	O
Q	Q	NN	I-NP	O
wave	wave	VBP	B-VP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
R	R	NN	I-NP	O
wave	wave	NN	I-NP	O
progression	progression	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
1991	1991	CD	B-NP	O
showed	show	VBD	B-VP	O
LVH	LVH	NN	B-NP	B-protein
with	with	IN	B-PP	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
rule	rule	NN	B-NP	O
out	out	IN	B-PP	O
MI	MI	NN	B-NP	O
three	three	CD	B-NP	O
months	month	NNS	I-NP	O
prior	prior	RB	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Sleep	Sleep	JJ	B-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Peptic	Peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Codeine	Codeine	NN	B-NP	O
which	which	WDT	B-NP	O
produces	produce	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

CARDIAC	CARDIAC	NN	B-NP	B-protein
RISK	RISK	NN	I-NP	I-protein
FACTORS	FACTORS	NNS	I-NP	I-protein
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Family	Family	RB	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

No	No	DT	B-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Hysterectomy	Hysterectomy	NN	B-NP	O
vaginally	vaginally	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
an	an	DT	B-NP	O
umbilical	umbilical	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Azmacort	Azmacort	NNP	B-NP	O
,	,	,	O	O
Proventil	Proventil	NNP	B-NP	O
,	,	,	O	O
Tagamet	Tagamet	NNP	B-NP	O
,	,	,	O	O
Cardizem	Cardizem	NNP	B-NP	O
300	300	CD	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
40	40	CD	B-NP	O
units	unit	NNS	I-NP	O
q.AM	q.AM	NN	B-NP	O
and	and	CC	O	O
55	55	CD	B-NP	O
units	unit	NNS	I-NP	O
q.PM	q.PM	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Motrin	Motrin	NNP	B-NP	O
,	,	,	O	O
Maxide	Maxide	NNP	B-NP	O
1	1	CD	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
140/80	140/80	CD	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
black	black	JJ	I-NP	O
female	female	NN	I-NP	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
at	at	IN	B-PP	O
45	45	CD	B-NP	O
degrees	degree	NNS	I-NP	O
with	with	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
head	head	NN	I-NP	O
was	be	VBD	B-VP	O
normocephalic	normocephalic	JJ	B-ADJP	O
atraumatic	atraumatic	JJ	I-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
round	round	JJ	I-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extraocular	extraocular	JJ	I-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
full	full	JJ	B-ADJP	O
.	.	.	O	O

Cranial	Cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
oral	oral	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
CVA	CVA	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
chest	ch	JJS	I-NP	O
wall	wall	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
non-tender	non-tender	JJ	I-ADJP	O
,	,	,	O	O
with	with	IN	B-SBAR	O
bowel	bowel	NN	B-NP	O
sounds	sound	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
,	,	,	O	O
clubbing	clubbing	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
proprioceptive	proprioceptive	JJ	I-NP	O
defects	defect	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Laboratories	Laboratory	NNS	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
3.7	3.7	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
11/1	11/1	CD	B-NP	O
.2	.2	NN	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
of	of	IN	B-PP	O
148	148	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
of	of	IN	B-PP	O
0.0	0.0	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
90	90	CD	B-NP	O
with	with	IN	B-PP	O
Q	Q	NN	B-NP	B-protein
waves/poor	waves/poor	NN	I-NP	I-protein
R	R	NN	I-NP	I-protein
wave	wave	VBP	B-VP	O
progression	progression	NN	B-NP	O
in	in	IN	B-PP	O
I	I	PRP	B-NP	O
,	,	,	O	O
III	III	CD	B-NP	O
,	,	,	I-NP	O
IV	IV	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
ruled	rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
serial	serial	JJ	B-NP	O
CPK	CPK	NN	I-NP	B-protein
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
serial	serial	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
0.0	0.0	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
VQ	VQ	NN	I-NP	O
scan	scan	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
sedentary	sedentary	JJ	I-NP	O
life	life	NN	I-NP	O
style	style	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
pulmonary	pulmonary	JJ	B-NP	O
embolus	embolus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-NP	O
low	low	JJ	I-NP	O
probability	probability	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Prilosec	Prilosec	NN	B-NP	O
and	and	CC	I-NP	O
Cisapride	Cisapride	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
complained	complain	VBN	I-VP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
worsening	worsen	VBG	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
laid	lay	VBD	B-VP	O
back	back	RB	B-ADVP	O
flat	flat	JJ	B-ADJP	O
and	and	CC	O	O
some	some	DT	B-NP	O
sour	sour	JJ	I-NP	O
taste	taste	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
medications	medication	NNS	B-NP	O
made	make	VBD	B-VP	O
her	her	PRP	B-NP	O
feel	feel	VB	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
better	good	JJR	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
finally	finally	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
with	with	IN	B-PP	O
MIBI	MIBI	NN	B-NP	B-protein
10/1/96	10/1/96	CD	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
went	go	VBD	B-VP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
0	0	CD	B-NP	O
seconds	second	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Bruce	Bruce	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
,	,	,	O	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
peak	peak	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
140	140	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
maximum	maximum	NN	I-NP	O
was	be	VBD	B-VP	O
120	120	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
atypical	atypical	JJ	I-ADJP	O
and	and	CC	O	O
ill	ill	RB	B-ADJP	O
defined	define	VBN	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
had	have	VBD	B-VP	O
MIBI	MIBI	NNP	B-NP	O
images	image	NNS	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
borderline	borderline	NN	I-NP	O
to	to	TO	B-PP	O
minimal	minimal	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
reversible	reversible	JJ	I-NP	O
defect	defect	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
that	that	DT	B-NP	O
was	be	VBD	B-VP	O
as	as	RB	O	O
said	say	VBN	B-NP	O
borderline	borderline	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
suitable	suitable	JJ	B-ADJP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
after	after	IN	B-PP	O
conversation	conversation	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Dubin	Dubin	NNP	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
following	follow	VBG	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
medication	medication	NN	I-NP	O
changes	change	NNS	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
Prilosec	Prilosec	NN	B-NP	O
and	and	CC	I-NP	O
Cisapride	Cisapride	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
place	place	NN	I-NP	O
of	of	IN	B-PP	O
Axid	Axid	NNP	B-NP	O
AND	AND	CC	O	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
isordil	isordil	NN	B-NP	O
10mg	10mg	CD	I-NP	O
po	po	NN	I-NP	O
tid	tid	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Proventil	Proventil	NN	B-NP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaler	inhal	JJR	B-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
enteric	enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
40	40	CD	I-NP	O
units	unit	NNS	I-NP	O
q.AM	q.AM	NN	I-NP	O
and	and	CC	O	O
55	55	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.PM	q.PM	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Maxide	Maxide	NN	B-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
1	1	CD	I-NP	I-protein
tablet	tablet	NN	I-NP	I-protein
sublingual	sublingual	JJ	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
5	5	CD	B-NP	I-protein
minutes	minute	NNS	I-NP	I-protein
times	time	NNS	I-NP	I-protein
three	three	CD	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Azmacort	Azmacort	NN	B-NP	O
4	4	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaler	inhal	JJR	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Cardizem	Cardizem	NNP	B-NP	O
CD	CD	NNP	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Cisapride	Cisapride	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
isordil	isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
tid	tid	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
SHELTON	SHELTON	NNP	B-NP	O
BUEL	BUEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
WI50	WI50	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JAMEY	JAMEY	NNP	B-NP	O
L.	L.	NNP	I-NP	O
GOLOMBECKI	GOLOMBECKI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
TX9	TX9	NNP	I-NP	O
KJ699/2717	KJ699/2717	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
11832	11832	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

O8DQKT47X4	O8DQKT47X4	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/10/96	11/10/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/26/96	9/26/96	CD	B-NP	O

